Cerca e trova il CMO / CDMO di cui hai bisogno
Discover highly skilled partners for your drug development and manufacturing project.
Showing 21 facilities
…
Stati Uniti
Lifecore Injectables CDMO
Lifecore Biomedical
CDMO che produce prodotti farmaceutici iniettabili sterili clinici e commerciali.
MERCATI: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
COMPLIANCE: EMA (GMP UE), ANVISA (Brazil B-GMP), TGA (Australia GMP), FDA (cGMP), ECOVADIS, ISO, Health Canada (Canada GMP), MFDS/KFDA (Repubblica di Corea GMP)
SOSTANZE CONTROLLATE: Lowest potential for abuse
BSL (Livello di sicurezza biologica): 3, 1, 2
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
REGIONE: North America
Stati Uniti
Pharmaron API Commercial Synthesis Coventry (US)
Pharmaron
Sintesi di piccole molecole API commerciali.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
USO: Umano, Veterinario
MERCATI: PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada), MHRA (UK)
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
SERVIZI: Manufacturing services, Development services
REGIONE: North America
COMPLIANCE: FDA (cGMP), ECOVADIS, ISO
CATEGORIA / PRODOTTO: CHEMICAL-SYNTHETIC
Stati Uniti
Avara Pharmaceutical Services | Arecibo Site
AVARA
Impianto di produzione di dosaggi solidi orali (OSD) su scala commerciale con una forte esperienza nelle sostanze controllate (DEA II V).
DIMENSIONE DEL LOTTO: Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (GMP UE), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Repubblica di Corea GMP), ICH
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
MERCATI: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada)
USO: Umano
SERVIZI: Analytical / QC services, Manufacturing services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
REGIONE: North America
Stati Uniti
Avara Pharmaceutical Services | Norman Site
AVARA
Impianto di produzione a contratto specializzato nel dosaggio solido orale (OSD) per la fornitura clinica e commerciale.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (GMP UE), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Repubblica di Corea GMP), ICH
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
MERCATI: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada), MHRA (UK)
USO: Umano
SERVIZI: Analytical / QC services, Manufacturing services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
REGIONE: North America
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
USO: Umano
SERVIZI: Logistics, Manufacturing services, Packaging
REGIONE: North America
MERCATI: FDA (USA), Health Canada (Canada)
COMPLIANCE: FDA (cGMP), NSF, Consiglio di ricerca halal, Health Canada (Canada GMP)
CATEGORIA / PRODOTTO: NUTRACEUTICI
Stati Uniti
Northway Biotech Waltham (MA)
Northway Biotech
CDMO globale sui prodotti biologici end-to-end
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES, BIOLOGIA
MERCATI: EDE (UAE), PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), SFDA (Saudi Arabia), Health Canada (Canada), MHRA (UK)
COMPLIANCE: EMA (GMP UE), PMDA/MHLW (Japan GMP), Servizio pubblico francese (CIR), FDA (cGMP), SFDA (Saudi Food & Drug Authority), ISO
BSL (Livello di sicurezza biologica): 3, 1, 2
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services
REGIONE: North America
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)
Stati Uniti
Adare Pharma | US
Adare Pharma Solutions
Adare Pharma è un CDMO globale con installazioni in EE.UU. e l'UE, che offre lo sviluppo di prodotti da lasciare in mano grazie all'esperienza nella fabbricazio
MERCATI: DIGEMID (Peru), ANMAT (Argentina), EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING
COMPLIANCE: EMA (GMP UE), PMDA/MHLW (Japan GMP), UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), MHRA (UK GMP), Servizio pubblico francese (CIR), TGA (Australia GMP), FDA (cGMP), NMPA (Cina GMP), ECOVADIS, ISO, Consiglio di ricerca halal, Health Canada (Canada GMP), TITCK (Turkish Health Authorities), MFDS/KFDA (Repubblica di Corea GMP)
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
REGIONE: North America
AREE TERAPEUTICHE DI COMPETENZA (ATC): (C) Cardiovascular system, (A) Digestive tract and metabolism
Limited view
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Organizzazione per lo sviluppo e la produzione a contratto (CDMO) con particolare attenzione alle proteine ricombinanti e agli anticorpi monoclonali (mAb).
Location available after registration
Limited view
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Ricerca e sviluppo e servizi analitici, trasferimento tecnologico e introduzione di nuovi prodotti e produzione di forme di dosaggio orale solide e liquide.
Location available after registration
Limited view
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Laboratorio di ricerca e sviluppo a contratto (CRDO) con sede negli Stati Uniti che fornisce servizi di sviluppo di prodotti farmaceutici.
Location available after registration
More facilities on the network
Register to unlock the full catalog with contact details and locations.
+11 more facilities
Create free account